EPISODE · Oct 31, 2022 · 13 MIN
BIO leadership shakeup followed clashes with board
from POLITICO's Pulse Check · host POLITICO
The leading industry group for biopharmaceutical companies is reeling after the departure of its CEO — just as the Biden administration is poised to begin implementing a new law aimed at reducing drug prices and as the balance of power could shift in Congress. Megan Wilson talks with Katherine Ellen Foley about the turmoil at the industry group. Plus, Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
The leading industry group for biopharmaceutical companies is reeling after the departure of its CEO — just as the Biden administration is poised to begin implementing a new law aimed at reducing drug prices and as the balance of power could shift in Congress. Megan Wilson talks with Katherine Ellen Foley about the turmoil at the industry group. Plus, Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
BIO leadership shakeup followed clashes with board
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 14, 2026 ·2m